|"One Flew Over the Cuckoo's Nest" a classic film about the mislabelling and misdiagnosis of mental illness and societal pressures to conform to norms of behaviour.
To watch Channel 4 'Special Report' click on link above.
Commission of Chhildren's Human Rights 2010
In March 2009, the American Psychiatric Association announced that it would phase out pharmaceutical funding of continuing medical education seminars and meals at its conventions. However, the decision came only after years of controversial exposure of its conflict of interest with the pharmaceutical industry and the U.S. Senate Finance Committee requesting in July 2008 that the APA provide accounts for all of its pharmaceutical funding. Despite its announcement, within two months, the APA accepted more than $1.7 million in pharmaceutical company funds for its annual conference, held in San Francisco.
Not surprising. In 2002, the APA’s Anand Pandya said that without pharmaceutical industry funds, membership dues could escalate 455% from $540 a year to $3,000. Pandya is president of the National Alliance on Mental Illness (NAMI), which in 2009 was also asked to provide records of its pharmaceutical company funding to federal investigators. About 56% of its $12 million-a-year income comes from drug makers (more below).
Within a month of the APA’s announcement, its conflicts came under criticism again with the release of a study that found that 18 of the 20 members overseeing the revision of clinical guidelines for treating just three “mental disorders” had financial ties to drug companies. The common diagnoses generate some $25 billion a year in pharmaceutical sales.
Psychiatrists Top the List of Drug Maker Gifts.
In June 2007, The New York Times reported that psychiatrists in Vermont and Minnesota topped the list of doctors receiving pharmaceutical company gifts and that this financial relationship corresponds to the “growing use of atypicals [new antipsychotics] in children.” From 2000 to 2005, drug maker payments to Minnesota psychiatrists rose more than six-fold to $1.6 million. During those same years, prescriptions of antipsychotics for children under the state’s insurance program rose more than nine-fold.
Conflicts Under Congressional Investigation
With the U.S. prescribing antipsychotics to children and adolescents at a rate six times greater than the U.K., and with 30 million Americans having taken antidepressants for a “chemical imbalance” that psychiatrists admit is a pharmaceutical marketing campaign, not scientific fact, it is no wonder that the conflict of interest between psychiatry and Big Pharma is under congressional investigation. The following is a summary of some of those under Senate Finance Committee investigation:
KNOWING THIS THERE IS ONLY ONE LOGICAL COURSE OF ACTION AND THAT IS TO BLOCK THE RELEASE OF DSM5 IN 2013 IN THE U.K.
THE GOVERNMENT MUST ACT SWIFTLY.